Recent News

• 04.01.2025 - Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit
• 03.17.2025 - Quanterix Corporation Q4 2024 Earnings Call
• 03.17.2025 - Quanterix Releases Financial Results for the Fourth Quarter of 2024
• 03.13.2025 - Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025
• 03.03.2025 - Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

Recent Filings

• 03.28.2025 - 8-K Current report
• 03.28.2025 - S-4/A Registration of securities, business combinations
• 03.19.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.18.2025 - 425 Prospectuses and communications, business combinations
• 03.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.17.2025 - 8-K Current report
• 03.17.2025 - 425 Prospectuses and communications, business combinations
• 03.17.2025 - DFAN14A Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
• 03.17.2025 - EX-99.1 EX-99.1